Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ketoreductase (KRED) Reduction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102978249A details a single-enzyme biocatalytic route for statin intermediates. Achieve >99% ee with simplified workup and reduced manufacturing costs.
Patent CN105985990B details a green enzymatic route for phenylephrine intermediates using KRED and antioxidants, offering significant cost reduction in API manufacturing.
Patent CN103468757A details a green enzymatic reduction for Atazanavir intermediates, offering high purity and safer manufacturing for pharmaceutical supply chains.